PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

Making headway on beta-blockers and sleep

Researchers at Brigham and Women's Hospital have found that melatonin supplementation significantly improved sleep in hypertensive patients taking beta-blockers

2012-09-28
(Press-News.org) Boston, MA—Over 20 million people in the United States take beta-blockers, a medication commonly prescribed for cardiovascular issues, anxiety, hypertension and more. Many of these same people also have trouble sleeping, a side effect possibly related to the fact that these medications suppress night-time melatonin production. Researchers at Brigham and Women's Hospital (BWH) have found that melatonin supplementation significantly improved sleep in hypertensive patients taking beta-blockers.

The study will be electronically published on September 28, 2012 and will be published in the October print issue of SLEEP.

"Beta-blockers have long been associated with sleep disturbances, yet until now, there have been no clinical studies that tested whether melatonin supplementation can improve sleep in these patients," explained Frank Scheer, PhD, MSc, an associate neuroscientist at BWH, and principal investigator on this study. "We found that melatonin supplements significantly improved sleep."

The research team analyzed 16 hypertensive patients who regularly took beta-blockers as treatment for their hypertension. The study participants were given either a melatonin supplement or placebo to take each night before bed. To avoid bias, neither the participants nor the researchers knew which pill they were taking. During the three week study, the participants spent two separate four-day visits in lab. While in the lab, the researchers assessed the participants' sleep patterns and found a 37-minute increase in the amount of sleep in the participants who received the melatonin supplement compared to those who received placebo. They also found an eight percent improvement of sleep efficiency and a 41 minute increase in the time spent in Stage 2 sleep, without a decrease in slow wave sleep or REM sleep.

"Over the course of three weeks, none of the study participants taking the melatonin showed any of the adverse effects that are often observed with other, classic sleep aids. There were also no signs of 'rebound insomnia' after the participants stopped taking the drug," explained Scheer, who is also an assistant professor of Medicine at Harvard Medical School. "In fact, melatonin had a positive carry-over effect on sleep even after the participants had stopped taking the drug."

The researchers caution that while this data is promising for hypertensive patients taking beta-blockers, more research is needed to determine whether patients taking beta-blockers for causes other than hypertension could also benefit from melatonin supplementation.

### The other authors on the publication are Christopher Morris, Joanna Garcia, Carolina Smales, Erin Kelly, Jenny Marks, Atul Malhotra, and Steven Shea.

This research was supported by NIH-R21 AT002713 and NIH-P30 HL101299 to Dr. Scheer and NCRR GCRC M01 RR02635 and UL1 RR025758, Harvard Clinical and Translational Science Center; National Space Biomedical Research Institute through NASA NCC 9-58 in support of Dr. Morris; NIH-K24 HL 093218 in support of Dr. Malhotra; NIH-K24 HL076446 in support of Dr. Shea.

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs nearly 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $625 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies, OurGenes and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom.


ELSE PRESS RELEASES FROM THIS DATE:

Effective HIV care benefited all HIV patients, regardless of demographics and behavioral risk

2012-09-28
Improved treatment options, a multi-pronged treatment model, and federal funding from the Ryan White Program have helped an inner city Baltimore clinic improve outcomes for HIV patients across all groups, including those most often hardest hit by the disease. Published in Clinical Infectious Diseases, the results from the 15-year analysis of patients at a clinic serving a primarily poor, African-American patient population with high rates of injection drug use demonstrate what state-of-the-art HIV care can achieve, given appropriate support. Current antiretroviral therapy ...

Eliminating invasive cervical cancer possible, Moffitt Cancer Center researchers report

2012-09-28
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer. "The good news is that over the past several decades, the incidence of invasive cervical cancer has declined dramatically," said senior author Anna R. Giuliano, Ph.D., director of Moffitt's Center for Infection Research in Cancer and senior member of the Cancer Epidemiology Department. "The bad ...

Gout guidelines arm patients and physicians with tools to fight painful disease

2012-09-28
Gout is one of the most common forms of inflammatory arthritis, affecting nearly 4% of adult Americans. Newly approved guidelines that educate patients in effective methods to prevent gout attacks and provide physicians with recommended therapies for long-term management of this painful disease are published in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR). Uric acid is produced by the metabolism of purines, which are found in foods and human tissue. When uric acid levels increase, crystals can form and deposit in joints, ...

Eating cherries lowers risk of gout attacks by 35%

2012-09-28
A new study found that patients with gout who consumed cherries over a two-day period showed a 35% lower risk of gout attacks compared to those who did not eat the fruit. Findings from this case-crossover study published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), also suggest that risk of gout flares was 75% lower when cherry intake was combined with the uric-acid reducing drug, allopurinol, than in periods without exposure to cherries or treatment. Previous research reports that 8.3 million adults in the U.S. suffer with gout, ...

Learning to live on mars

2012-09-28
Boston, MA—Since the beginning of August, NASA's Mars rover, Curiosity, has been roaming all over the distant planet learning as much as it can about the Martian terrain. The mission control team back on Earth has also learned what it may be like on Mars by trying to live and work on a Martian day, which is about 40 minutes longer than an Earth day. This 'day' length causes havoc with the internal 24-hour body clock but researchers at Brigham and Women's Hospital (BWH) have developed and tested a fatigue management program which is successful at controlling this space-age ...

Baumann Group Appoint Carbon Finance Management Strategist.

2012-09-28
Mike Rutherford is a business process and project management consultant who specializes in developing strategies to help companies deal with the transitions and climate change policies relative to the energy sector; and he has done so since 1999. "Mike Rutherford will analyze Baumann Group's business process and how they integrate their key systems into every project" stated a source close to the management team at Baumann Group. "Mike has an extensive background in successfully combining his experience and skills honed over 25 years. He will revamp ...

Content Marketing Firm Sumèr, LLC, Announces Launch of a Newly Branded Website and Expanded Core Services

2012-09-28
In an effort to better serve clients, copywriting and content marketing firm Sumèr, LLC, launches a new brand image and website to better reflect the company's personality and to attract and connect with new and ideal clients. Over the years, Sumèr has catered to overwhelmed companies who want to grow fast, and are in need of a big picture strategy that is executed quickly. And in order to streamline these measures, the new website will feature two new core services in addition to the current copywriting offerings. When asked about these new services, CEO Michelle ...

Turzain Unveils Portugal Property Rental Website Revamp

2012-09-28
Turzain, the family-run expert in luxury long- and short-term accommodation in Portugal, is pleased to announce the launch of its new-look website. The modified website has a clean design and invites visitors to learn more about Portugal with plenty of new features. http://www.turzain.com. In addition to offering luxurious apartment rentals in the areas of Cascais, the Algarve, and Lisbon, the new Turzain website also expertly informs visitors about Portuguese culture. The website's professional and user-friendly design complements Turzain's ethos for a friendly and ...

Fans "Green Light" Showgirls the Musical -- Dates Added

2012-09-28
Two Chicagoans are producing a musical version of the cult-classic movie, Showgirls, this October at Chicago's Stage 773. Having raised funding for the project this summer on Kickstarter—a digital fundraising program for artists and dreamers—Showgirls the Musical more-than hit it's fundraising goal on July 29: essentially giving the "green light" to A Touch Too Much productions as they build their musical—the answer to every middle-aged gay man's prayers. With rehearsals currently underway, an enthusiastic cast of 8 works day and night to bring the pieces of ...

Stellar Announces New Sunshine Coast Location for Australian Taxation Office Contact Centre

2012-09-28
As the fourth largest local government in Australia, the Sunshine Coast region provides a large, diverse labour catchment area and a robust economy to support the large scale operation. "I am looking forward to Stellar achieving great things here on the Coast, and the company will have our support all the way," said Mark Jamieson, Mayor and Economic Portfolio holder. Melissa Hamilton, CEO Stellar (Asia Pacific) recently said, "We are really proud and excited to be bringing so many employment opportunities to the Sunshine Coast. We've always been a big ...

LAST 30 PRESS RELEASES:

Scientists model 'true prevalence' of COVID-19 throughout pandemic

New breakthrough to help immune systems in the fight against cancer

Through the thin-film glass, researchers spot a new liquid phase

Administering opioids to pregnant mice alters behavior and gene expression in offspring

Brain's 'memory center' needed to recognize image sequences but not single sights

Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions

Changes in disparities in access to care, health after Medicare eligibility

Use of high-risk medications among lonely older adults

65+ and lonely? Don't talk to your doctor about another prescription

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

Plant root-associated bacteria preferentially colonize their native host-plant roots

Rare inherited variants in previously unsuspected genes may confer significant risk for autism

International experts call for a unified public health response to NAFLD and NASH epidemic

International collaboration of scientists rewrite the rulebook of flowering plant genetics

Improving air quality reduces dementia risk, multiple studies suggest

Misplaced trust: When trust in science fosters pseudoscience

Two types of blood pressure meds prevent heart events equally, but side effects differ

New statement provides path to include ethnicity, ancestry, race in genomic research

Among effective antihypertensive drugs, less popular choice is slightly safer

Juicy past of favorite Okinawan fruit revealed

Anticipate a resurgence of respiratory viruses in young children

Anxiety, depression, burnout rising as college students prepare to return to campus

Goal-setting and positive parent-child relationships reduce risk of youth vaping

New research identifies cancer types with little survival improvements in adolescents and young adul

Oncotarget: Replication-stress sensitivity in breast cancer cells

Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas

Development of a novel technology to check body temperature with smartphone camera

The mechanics of puncture finally explained

Extreme heat, dry summers main cause of tree death in Colorado's subalpine forests

[Press-News.org] Making headway on beta-blockers and sleep
Researchers at Brigham and Women's Hospital have found that melatonin supplementation significantly improved sleep in hypertensive patients taking beta-blockers